A commercial air-fed and piezoelectric-driven plasma pen (piezobrush®, relyon plasma GmbH, Regensburg, Germany) including three different nozzles was investigated for its suitability as a medical plasma device. In this regard, potential risk factors for human health, which originate from gas temperature, thermal output, patient leakage current, ultraviolet radiation and gas emissions, were assessed according to DIN SPEC 91315:2016–06. As a result, safe treatment distances were determined for each nozzle. The antimicrobial efficacy was investigated subsequently by inhibition zone assays with five different clinical relevant microorganisms. All results were compared to an approved medical plasma source fed with argon (kINPen® MED, neoplas tools GmbH, Greifswald, Germany). It was observed that the antimicrobial efficacy differs not only between the two devices as a result from different feed gases, but also between the nozzles. This could be traced back to a different plasma chemistry, which accompanying Fourier-transform infrared absorption spectroscopy suggests. The measured physical properties of the piezoelectric plasma pen at the determined operating parameters do not show human health risks. Due to its distinct antimicrobial efficacy, the piezoelectric plasma pen shows a high potential for a medical application.
A non-thermal plasma source based on a surface dielectric barrier discharge (DBD) is developed for purification of recirculating air in operating theatres in hospitals. This is a challenging application due to high flow rates, short treatment times and the low threshold for ozone in the ventilated air. Therefore, the surface DBD was enhanced in order to generate an ionic wind, which can deflect and thus, filter out airborne microorganisms. Electrical and gas diagnostics as well as microbiological experiments were performed in a downscaled plasma source under variation of various electrical parameters, but application-oriented airflow velocity and humidity. The dependence of electrical power and ozone concentration as well as charged particles in the plasma treated air on frequency, voltage and relative humidity is presented and discussed. The presence of humidity causes a more conductive dielectric surface and thus a weaker plasma formation, especially at low frequency. The airborne test bacteria, Escherichia coli, showed significant effect to plasma treatment (up to 20% reduction) and to plasma with ionic wind (up to 90% removal); especially a configuration with 70% removal and an accompanying ozone concentration of only 360 ppb is promising for future application.
Airborne bacteria are a general problem in medical or health care facilities with a high risk for nosocomial infections. Rooms with a continuous airflow, such as operation theaters, are of particular importance due to a possible dissemination and circulation of pathogens including multidrug‐resistant microorganisms. In this regard, a cold atmospheric‐pressure plasma (CAP) may be a possibility to support usual disinfection procedures due to its decontaminating properties. The aim of this study was to determine the antimicrobial efficacy of a plasma decontamination module that included a dielectric barrier discharge for plasma generation. Experimental parameters such as an airflow velocity of 4.5 m/s and microbial contaminations of approximately 6,000 colony‐forming units (cfu)/m3 were used to simulate practical conditions of a ventilation system in an operating theater. The apathogenic microorganism Escherichia coli K12 DSM 11250/NCTC 10538 and the multidrug‐resistant strains E. coli 21181 and 21182 (isolated from patients) were tested to determine the antimicrobial efficacy. In summary, the number of cfu was reduced by 31–89% for the tested E. coli strains, whereby E. coli K12 was the most susceptible strain toward inactivation by the designed plasma module. A possible correlation between the number or kind of resistances and susceptibility against plasma was discussed. The inactivation of microorganisms was affected by plasma intensity and size of the plasma treatment area. In addition, the differences of the antimicrobial efficacies caused through the nebulization of microorganisms in front (upstream) or behind (downstream) the plasma source were compared. The presence of ionic wind had no influence on the reduction of the number of cfu for E. coli K12, as the airflow velocity was too high for a successful precipitation, which would be a prerequisite for an increased antimicrobial efficacy. The inactivation of the tested microorganisms confirms the potential of CAP for the improvement of air quality. The scale‐up of this model system may provide a novel tool for an effective air cleaning process.
Desktop laser cutters are an affordable and flexible rapid-prototyping tool, but some materials cannot be safely processed. Among them is polyvinyl chloride (PVC), which users usually cannot distinguish from other, unproblematic plastics. Therefore, an identification system for PVC applicable in a low-cost laser cutter has been developed. For the first time, this approach makes use of the laser-ablative sound generated by a low-power laser diode. Using a capacitor microphone, a preprocessing algorithm and a very simple neural network, black PVC could be detected with absolute reliability under ideal conditions. With ambient noise, the accuracy dropped to 80%. A different color of the material did not influence the accuracy to detect PVC, but a susceptibility of the method against a color change was found for other materials. The ablation characteristics for different materials were recorded using a fast-framing camera to get a better insight into the mechanisms behind the investigated process. Although there is still potential for improvements, the presented method was found to be promising to enhance the safety of future desktop laser cutters.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.